BioCryst Pharma
(NASDAQ:BCRX)
$4.77
0[0.00%]
At close: Apr 15
$4.77
0[0.00%]
After Hours: 4:45PM EDT
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

BioCryst Pharma Stock (NASDAQ:BCRX), Quotes and News Summary

BioCryst Pharma Stock (NASDAQ: BCRX) stock price, news, charts, stock research, profile.

Open$4.780
Close$4.670
Volume / Avg.2.497M / 3.085M
Day Range4.590 - 4.785
52 Wk Range4.450 - 9.065
Market Cap$983.335M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
43
Short Interest
17.4%
Days to Cover10.1

Recent News

What's Going On With BioCryst Stock After Earnings?
BioCryst reported quarterly losses of 28 cents per share, missing the analyst consensus estimate of losses of 24 cents by 16.67% and representing a 26.32% increase over losses of 38 cents per share from the same period last year. The company reported quarterly sales of $93.4 million which beat the analyst consensus estimate of $90.01 million by 3.77% and is a 17.42% increase over sales of $79.55 million from the prior year's quarter.
Erica Kollmann
Li Auto Posts Q4 Earnings, Joins Teva Pharmaceutical And Other Big Stocks Moving Higher In Monday's Pre-Market Session
U.S. stock futures were lower this morning, with the Dow futures trading lower by over 50 points on Monday.
Avi Kapoor
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on the stock and raised its price target from $35 to $41.
Avi Kapoor
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
2
Nov 23
1
Jan
1
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
3.7
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About Biocryst Pharmaceuticals Inc.
Sector
Health Care
Industry
Biotechnology
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and developm...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
BCRX
MGNX

FAQ

Q

How do I buy BioCryst Pharma (BCRX) stock?

A

You can purchase shares of BioCryst Pharma (NASDAQ: BCRX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are BioCryst Pharma's (BCRX) competitors?

A

Other companies in BioCryst Pharma’s space includes: Macrogenics (NASDAQ:MGNX), ARS Pharmaceuticals (NASDAQ:SPRY), Cabaletta Bio (NASDAQ:CABA), 89bio (NASDAQ:ETNB) and Zentalis Pharma (NASDAQ:ZNTL).

Q

What is the target price for BioCryst Pharma (BCRX) stock?

A

The latest price target for BioCryst Pharma (NASDAQ: BCRX) was reported by Needham on Wednesday, April 10, 2024. The analyst firm set a price target for 12.00 expecting BCRX to rise to within 12 months (a possible 151.57% upside). 15 analyst firms have reported ratings in the last year.

Q

Current Stock Price for BioCryst Pharma (BCRX)?

A

The stock price for BioCryst Pharma (NASDAQ: BCRX) is $4.77 last updated April 15, 2024 at 4:45 PM EDT.

Q

Does BioCryst Pharma (BCRX) pay a dividend?

A

There are no upcoming dividends for BioCryst Pharma.

Q

When is BioCryst Pharma (NASDAQ:BCRX) reporting earnings?

A

BioCryst Pharma’s Q1 earnings are confirmed for Wednesday, May 1, 2024.

Q

Is BioCryst Pharma (BCRX) going to split?

A

There is no upcoming split for BioCryst Pharma.

Q

What sector and industry does BioCryst Pharma (BCRX) operate in?

A

BioCryst Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch